Compare ATCH & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATCH | INCR |
|---|---|---|
| Founded | 2022 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 47.4M |
| IPO Year | 2024 | 2021 |
| Metric | ATCH | INCR |
|---|---|---|
| Price | $0.22 | $0.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 36.5K |
| Earning Date | 05-15-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $84.47 | $69.54 |
| Revenue Next Year | $39.32 | $41.75 |
| P/E Ratio | $4.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $0.68 |
| 52 Week High | $1.92 | $1.77 |
| Indicator | ATCH | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 35.18 | 51.85 |
| Support Level | $0.21 | $0.72 |
| Resistance Level | $0.24 | $0.91 |
| Average True Range (ATR) | 0.02 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 2.28 | 53.85 |
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.